CVS says blaming drug middlemen for higher prices is ‘deceptive rhetoric’
CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.
CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.
